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Lead Poisoning and Brain Cell Function
By Gary W. Goldstein*
Exposure to excessive amounts ofinorganic lead during the toddler years mayproduce lastingadverse effects
upon brain function. Maximal ingestion of lead occurs at an age when major changes are occurring in the
density ofbrain synaptic connections. The developmental reorganization of synapses is, in part, mediated by
protein kinases, and these enzymes are particularly sensitive to stimulation by lead. By inappropriately activat-
ing specific protein kinases, lead poisoning may disrupt the development ofneural networks without produc-
ing overt pathological alterations. The blood-brain barrier is anotherpotential vulnerable site for the neurotoxic
action of lead. Protein kinases appear to regulate the development ofbrain capillaries and the expression of
the blood-brain barrierproperties. Stimulation ofprotein kinase by lead may disrupt barrier development and
alter the precise regulation ofthe neuronal environment that is required for normal brain function. Ibgether,
these findings suggest that the sensitivity ofprotein kinases to lead may in part underlie the brain dysfunc-
tion observed in children poisoned by this toxicant.
Introduction
Subtle but convincing defects in cognitive function and
behavior occur in children with blood levels oflead frequently
encountered in the general population (1). If the adverse
effects described in the prospective studies of children
reported at this conference persist into adult life, we face
considerable loss from exposure to this environmental toxi-
cant. The mechanisms by which lead disrupts brain func-
tion and the reasons for the apparent heightened sensitivity
of the immature nervous system are not well understood.
The goal ofthis review is to describe two neural systems,
injury to either of which may underlie the developmental
vulnerability of the brain. A potential biochemical site for
the toxic action of lead is also described.
At a cellular level of organization, the brain can broadly
be divided into two components. The neurons with their
processes and insulating myelin are the information system,
while the endothelial cells and astrocytes that regulate the
fluid environment within brain are the homeostatic system.
Synaptogenesis
Neural networks are formed by interconnecting neurons
with extensive processes consisting ofdendrites that receive
and axons and nerve endings that transmit information (2).
In these networks, axons signal their targets (dendrites and
neuronal cell bodies) by release of neurotransmitters in
response to an excitatory depolarization ofthe axonal mem-
brane. The oligodendroglial cells surround the axons to form
the myelin sheath, which acts to speed the wave ofdepolar-
ization from the neuronal cell body to the nerve terminal.
Receptors on the dendrites and cell body respond to the
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neurotransmitters and summate excitatory and inhibitory
signals to produce episodic depolarization of the target
neuron. The combination ofa nerve terminal and its receptor
site on an adjacent neuron is termed a synapse. Since alarge
number ofnerve terminals converge on each target neuron,
the activity in the neural network can be exceedingly com-
plex, especially considering the number of neurons (101")
and synapses (1015) in the human brain. It is the pattern
of synaptic activity in these circuits that determines all
aspects of brain function: control of mobility, perceptions,
behavior, and ideas. If low-level exposure to lead alters
aspects ofbehavior, there must be a direct orindirect effect
of the toxin upon the function of certain neural networks.
Damage at low doses of lead, however, is not overt since
there is no pathologic indication ofbrain cell injury or death.
One clue to the toxic mechanism may be the develop-
mental vulnerability. Blood levels of lead peak between 18
and 36 months ofage, and it is the magnitude ofthese eleva-
tions that corresponds best with future neurobehavioral
deficits (3). Examination of the child's brain at this stage
ofdevelopment reveals anongoingreorganization ofdendrite-
nerve terminal connections. Almost all ofcerebral neurons
form during the second trimester of gestation and migrate
to their adult location well before birth. Neuronal connec-
tions at birth, however, are sparse compared to the adult
(4). This is reflected in a relatively low metabolic rate
measured by positive emission tomography scan (5). Dur-
ing the first 24 months oflife, a progressive increase occurs
in synaptic density and complexity paralleled by an increase
in cerebral metabolic rate. By the third year of life, both
measures exceed the normal adult pattern by almost 2-fold.
During the next stage ofbrain development, an apparent
pruning ofthese exuberant connections takes place so that
dendritic arborization and brain metabolic rate decline to adult
values. From infancy to 8 months, production of synapses
exceeds their removal, leading to a density of connectionsG. W. GOLDSTEIN
greater than that present at maturity. During subsequent
years, the rate of removal exceeds the rate of formation,
and the density of connection falls. Thereafter, formation
and disappearance reach an equilibrium that leaves the den-
sity of synapses at a nearly constant value.
This developmental pattern occurs in a numberofspecies
and appears to be genetically determined. However, given
the huge number of synapses (greater than 10's), individual
genes that number about 100,000 cannot control which syn-
apses are formed, retained, orlost. Current theories suggest
that survival of synaptic connections and dendrites occurs
by a Darwinian selection process resulting from competi-
tion for a limited amount of trophic factors and influenced
by the amount and complexity ofactivity in a given neuronal
circuit (6).
To consider how lead might disrupt this selection process,
it is necessary to understand the biochemical events that
modulate activity in the nerve terminal (7). Transmission
ofinformation (excitation or inhibition) from one neuron to
another is mediated by the release ofneurotransmitters at
specific nerve terminals. The sequence ofbiochemical events
that control neurotransmitter release appears to be similar
in most neurons. When the threshold for excitation at the
cell body is exceeded, the portion of the axon nearest the
cell body is depolarized by an opening ofsodium channels.
The resulting reversal ofelectrical potential produces a wave
of depolarization that travels down the axon to the nerve
terminal. When the nerve terminal itself is depolarized,
calciumchannels in the plasma membrane open, andcalcium
enters the terminal. This increase in calcium concentration
causes a fusion of neurotransmitter-containing membrane
vesicles with the plasma membrane and release oftheir con-
tents into the synapticjunction. Neurotransmitter molecules
are thereby made available for the receptors on the target
neuron, and activity is passed on to the next cell in the
network.
There are a number ofinfluences that modulate the sen-
sitivity of this sequence of events, and it is at this level of
control that the biochemical basis for synaptic remodeling
and learning appear to reside. With repeated depolarization
sequenced in an appropriate pattern, nerve terminals and
their associated target cell receptor zones become more ef-
ficient and may expand their surface area. The apparent
biochemical mediators ofthis enhanced efficiency are a class
ofenzymes called protein kinases (8). These enzymes facil-
itate the transfer ofthe terminal phosphate groupfromATP
to specific amino acids on regulatory proteins. Because phos-
phate groups are negatively charged, phosphorylation alters
the configuration and function of the target protein. Thus,
a protein that acts as a gate in a membrane channel may
open and allow more calcium to enter the nerve terminal
after depolarization. Another protein that acts as a recep-
tor for neurotransmitters may become less responsive to
neurotransmitters after phosphorylation. Enzymes involved
in neurotransmitter synthesis or breakdown are also sub-
ject to phosphorylation. Protein kinases are important to
the control of neural transmission and play a central role
inregulatingthe activity anddevelopment ofneuralnetworks.
Protein kinases are classified by the type ofintracellular
messengerby which they are activated. The major classes
ofintracellular messengers include cyclic AMP, cyclic GMP,
calmodutin, diacyglycerol, inositol triphosphate, and calcium.
In each case, the cascade of events initiating the activation
ofa protein kinase begins when aneurotransmitter (the first
messenger) occupies a receptor site on the cell surface. The
signalproducedbyreceptoroccupancyis transmittedthrough
the plasma membrane by a transduction molecule (G-
protein), which in turns stimulates an enzyme to produce
a soluble molecule (the intracellular second messenger) that
signals activation of its protein kinase. One such pathway
involves the breakdown ofa plasma membrane lipid, phos-
phoinositide bisphosphate, to two second messengers:
diacylglycerol and inositol triphosphate (9). Diacylglycerol,
in the presence ofcalcium, activates proteinkdnase C. Protein
kinase C in turn phosphorylates proteins in the nerve ter-
minal that enhance neurotransmitter release after depolariza-
tion, possibly by increasing calcium entry (10). In this way,
protein kinase C may influence synapse formation and
persistence.
We found that very low concentrations of lead appear
capable ofreplacing calcium in this reaction sequence (11).
Calcium inside a cell acts as a second messenger to activate
a wide variety of biochemical events in addition to protein
kinase C. Protein kinase C is, however, particularly sensi-
tive to the calciumlike effects oflead. By acting as a calcium
substitute, lead may disrupt the normal regulation ofprotein
kinase C. For example, prolonged activation ofthis enzyme
could produce sustained release ofneurotransmitters from
nerve terminals. Such unregulated activity would have a
number of disruptive effects. Depending upon the type of
neurotransmitter released, target neurons may have their
threshold for excitation raised or lowered. In addition, the
ability to modulate the neurotransmitter release mechanism
would be decreased if an important regulator like protein
kinase C has a diminished range ofresponse because ofsus-
tained stimulation by lead. This loss could limit the com-
plexity ofactivity in a neuralcircuit andplace those synapses
at a disadvantage during the developmental selection pro-
cess. In humans, the result may be diminished cognitive
function and altered behavior patterns. Such a pathologic
mechanism for the developmental toxicity oflead is consis-
tent with normal brain anatomy: the problem would not be
in number of neurons or synaptic connections but rather
with the inefficient manner in which synapses are formed
and retained (12).
Two other protein kinases in the nerve terminal may be
disruptedby the presence oflead. Surges in calcium concen-
tration within the nerve terminal alter the configuration of
calmodulin, a calcium-binding regulatory protein (13). Cal-
modulin serves as a sensor for the free concentration of
calcium inside the nerve terminal. When its binding sites
are occupied by calcium, calmodulin changes shape, binds
to, and activates regulatory proteins including enzymes and
transporters. Lead can replace calcium in this reaction and
activate several biochemical events normally regulated by
the concentration ofcalcium. Calmodulin stimulates a specific
protein kinase in the nerve terminal that phosphorylates
synapsin. Synapsin is a protein present in high concentra-
92BRAIN CELL FUNCTION
tions around synaptic vesicles, the storage packets for neuro-
transmitters in the nerve ending (8). When synapsin is
phosphorylated by calmodulin-protein kinase, the synaptic
vesicles are more sensitive to depolarization and release
more neurotransmitter into the synaptic cleft between the
nerve terminal and the dendrite. In this way, calmodulin-
protein kinase modulates the release ofneurotransmitters.
Normally, the concentration ofcalcium in the nerve terminal
is lower than that required to activate calmoduiin. One mech-
anism to elevate the calcium level is through the phos-
phoinositide second messenger system described above.
When phosphoinositide bisphosphate is hydrolyzed in re-
sponse to occupancy of a neurotransmitter receptor, two
second messengers are produced (9). One is the diacyl-
glycerol that activates protein kinase C, and the second is
inositol triphosphate, which causes release ofcalcium from
the endoplasmic reticulum into the cytosol of the nerve
termnal. Elevations in the concentration ofcalcium then acti-
vate calmodulin and its protein kinase to phosphorylate
synapsin and enhance neurotransmitter release. In a test
tube, lead activates calmoduiin in the absence of calcium
(14,15). Ifsuch activationoccurs in the intactnervous system,
control ofneurotransmitter release would be disturbed and
adjustments of neural net performance blunted.
Yet another type ofproteinkinase exists in the nerve ter-
minal. This one is activated by cyclic AMP, the second
messenger produced from ATP by adenylate cyclase after
external exposure of the neuron to fl-adrenergic neuro-
transmitters (8). Cyclic AMP activates a protein kinase that
also phosphorylates synapsin. In this case, lead may inhibit
the phosphorylation of synapsin because the toxin inhibits
the formation ofcyclicAMPbyadenylate cyclase (16). Cyclic
AMP levels may be even further depressed since the
enzyme that degrades cyclic AMP (cyclic AMP-phospho-
diesterase) is activated by calmoduiin in the presence oflead
(15). Thus, cyclic AMP levels may be diminished both by
lead inhibition of adenylate cyclase and lead stimulation of
phosphodiesterase.
All three protein kinases, protein kinase C, calmodulin-
protein kinase, and cyclic AMP-protein kinase, are present
in the nerve terminal and serve to modulate the release of
neurotransmitters. Although the exact steps are unclear,
modulation ofneurotransmitter release appears to be ofcen-
tralimportance to both short-term andlong-term cognitive
andbehavioral function. Regional selectivity in vulnerability
to lead may be explained by the differential location of the
various proteinkinases (17). In vitro studies ofleadtoxicity
suggest the following pattern ofsensitivity to lead: protein
kinase C > > calmodulin-protein kinase C > cyclic AMP
protein kinase (11,16,18).
In addition to effects upon neurotransmitter release, the
protein kinases, by means oftheirphosphorylated products,
signal the nucleus ofneurons to alter gene expression. Thus,
long-termalterations inneuralnetfunction maybe regulated
not only by biochemical events in the nerve terminal but
also by changes in nuclear function. Given the information
available, it would appear important to explore the effects
of lead upon gene function. Protein kinase C is of special
interest because it appears particularly sensitive to lead and
is known to be involved in regulating gene expression (19).
In nerve endings isolated from brain, lead stimulates the
basal release ofneurotransmitters (20). Although there are
multiple potential sites at which lead might produce these
changes, oneunifyinghypothesis is thatthe enhanced release
ofneurotransmitters is related to the stimulation ofprotein
kinase C by low doses of lead.
Blood-Brain Barrier
By altering protein kinase-mediated control of cell func-
tion, lead could also disrupt the function ofthe homeostatic
support system of the brain: the endothelial cells and the
astrocytes. The fluid environment of the nervous system
is maintained under strict control by the blood-brain barrier
(21). In contrastto otherorgans, the passage ofwater-soluble
molecules between the blood and the brain fluid spaces does
not occur by simple diffusion. Instead, selected molecules
including the essential amino acids, glucose, calcium, sodium
and potassium are transported across the capi0lary by means
of carriers located in the plasma membrane of brain endo-
thelial cells. These transport systems are highly specific and
exclude most nonessential water-soluble molecules. Else-
where in the body, there are gaps between capillary endo-
thelial cells that allow for the free passage ofmost dissolved
substances in the blood stream. This difference is impor-
tant for normal brain function because the concentrations
ofmany hormones and ions in the blood vary with diet and
stress and would interfere with brain function if they had
ready access to neurons. Thus, the small blood vessels in
brain have many special features resembling those found
in epithelial transport tissues such as the renal tubule. This
added complexity may underlie their vulnerability to injury
by toxicants.
Lead appears to be preferentially accumulated by endo-
thelial cells in brain (22). High-level exposure to lead results
in aloss ofnormalbarrierfunctionanda movementofplasma
into the interstitial fluid spaces ofbrain (23). Edema ensues
with increased intracranial pressure and diminished perfu-
sion ofthe brain with blood and its essential substrates (oxy-
gen and glucose). This cascade ofevents can and often does
produce irreversible brain damage. Exposure to low levels
of lead may change the microenvironment of the brain in
ways less overt than associated with the acute enceph-
alopathy that nevertheless interfere with normal develop-
mental processes.
Ourlaboratory investigates the effects oflead uponblood-
brain barrier development andfunction. For the most part,
studies are carried out in smal blood vessels freshiy isolated
from brain or in endothelial cells maintainedin tissue culture
(24). Although the endothelial cells and their tightjunctional
contacts create the blood-brain barrier, alarge bodyofinfor-
mation suggests thatthe signals importantforthe expression
ofthe barrier result from interactions between endothelial
cells and astrocytes (25). Astrocytes actually outnumber
neurons in the brain. Their processes surround the endo-
thelial cells andinterdigitate amongthe axons and dendrites
in areas ofsynaptic connections (2). We foundthatthe inter-
action between endothelial cells and astrocytes influence the
toxic action of lead (26).
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Control ofcell growth and differentiation is a particularly
well-established function ofprotein kinase C (19). Thus, the
sensitivity ofthis enzyme to lead may be relevant not only
to synaptogenesis, as discussed in the preceding section,
but also to the regulation ofpermeability at the blood-brain
barrier. To pursue this possibility, we investigated the acti-
vation ofprotein kinase C in isolated brain microvessels. We
found that low concentrations oflead cause a translocation
ofprotein kinase C from the cytosol to the membrane frac-
tion ofmicrovessels prepared from newborn rat brain (27).
Such a translocation is usually produced as a response to
growth factors and appears linked to the maturation ofbrain
endothelial cells. In normal rats, protein kinase C activity
in brain microvessels is in the cytosol until 10 to 15 days
of age, after which it associates with cellular membranes
(28). Our in vitro studies suggest that exposure to lead
causes a premature translocation of protein kinase C and
disrupts the normal developmental sequence. In this way,
lead could alterthe microenvironment ofthe brainanddisrupt
normal development without producing pathologic signs of
cell death or edema.
Summary
The neurobehavioral changes found in lead-poisoned
children may result from damage to the blood-brain barrier
or direct effects oflead upon neuronal activity and synapto-
genesis. A promising direction forfuture biochemical inves-
tigation is suggested by the sensitivity to lead of cell
messenger systems. Definition ofthe interaction oflead with
the binding of a neurotransmitter to cell surface receptors,
the transduction process producing intracellular second
messengers, the activation of specific protein kinases, and
the alterations ofcellular function and gene expression pro-
duced by phosphorylation ofregulatory proteins should be
pursued. A comprehensive investigation ofthese regulators
should provide new insights into the biologic basis for the
deficits that occurinchildren withlowlevel exposure tolead.
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